Renal and Hormonal Effects of Pioglitazone

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study examines the effects of pioglitazone on renal sodium handling in subjects prone to insulin resistance, i.e. diabetic and/or hypertensive subjects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Geneva
• Collaborator: University of Lausanne Hospitals
• Treatments: Insulin; Metformin; Pioglitazone

Criteria

Inclusion Criteria:

• Type II Diabetes

• Hypertension

Exclusion Criteria:

• Cardiac or renal diseases

• Anaemia

• Drugs like aspirin, non steroidal anti-inflammatory drugs and hormonal replacement therapy.